Literature DB >> 31677919

The Landscape of Atypical and Eukaryotic Protein Kinases.

Georgi K Kanev1, Chris de Graaf2, Iwan J P de Esch2, Rob Leurs2, Thomas Würdinger3, Bart A Westerman4, Albert J Kooistra5.   

Abstract

Kinases are attractive anticancer targets due to their central role in the growth, survival, and therapy resistance of tumor cells. This review explores the two primary kinase classes, the eukaryotic protein kinases (ePKs) and the atypical protein kinases (aPKs), and provides a structure-centered comparison of their sequences, structures, hydrophobic spines, mutation and SNP hotspots, and inhibitor interaction patterns. Despite the limited sequence similarity between these two classes, atypical kinases commonly share the archetypical kinase fold but lack conserved eukaryotic kinase motifs and possess altered hydrophobic spines. Furthermore, atypical kinase inhibitors explore only a limited number of binding modes both inside and outside the orthosteric binding site. The distribution of genetic variations in both classes shows multiple ways they can interfere with kinase inhibitor binding. This multilayered review provides a research framework bridging the eukaryotic and atypical kinase classes.
Copyright © 2019 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  SNP; catalytic kinase domain structures; eukaryotic and atypical protein kinases; oncogenic mutations; selective kinase inhibitor design; small-molecule kinase inhibitors

Mesh:

Substances:

Year:  2019        PMID: 31677919     DOI: 10.1016/j.tips.2019.09.002

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


  18 in total

1.  A Legionella effector kinase is activated by host inositol hexakisphosphate.

Authors:  Anju Sreelatha; Christine Nolan; Brenden C Park; Krzysztof Pawłowski; Diana R Tomchick; Vincent S Tagliabracci
Journal:  J Biol Chem       Date:  2020-03-30       Impact factor: 5.157

Review 2.  Advances in chemical proteomic evaluation of lipid kinases-DAG kinases as a case study.

Authors:  Timothy B Ware; Ku-Lung Hsu
Journal:  Curr Opin Chem Biol       Date:  2021-07-23       Impact factor: 8.822

Review 3.  Adenosine triphosphate energy-independently controls protein homeostasis with unique structure and diverse mechanisms.

Authors:  Jianxing Song
Journal:  Protein Sci       Date:  2021-04-13       Impact factor: 6.993

4.  Molecular Basis for Ser/Thr Specificity in PKA Signaling.

Authors:  Matthias J Knape; Maximilian Wallbott; Nicole C G Burghardt; Daniela Bertinetti; Jan Hornung; Sven H Schmidt; Robin Lorenz; Friedrich W Herberg
Journal:  Cells       Date:  2020-06-25       Impact factor: 6.600

5.  Exogenous bacterial DnaK increases protein kinases activity in human cancer cell lines.

Authors:  Francesca Benedetti; Sabrina Curreli; Robert C Gallo; Davide Zella
Journal:  J Transl Med       Date:  2021-02-09       Impact factor: 5.531

Review 6.  Moonlighting Proteins Shine New Light on Molecular Signaling Niches.

Authors:  Ilona Turek; Helen Irving
Journal:  Int J Mol Sci       Date:  2021-01-29       Impact factor: 5.923

7.  Prediction of kinase inhibitors binding modes with machine learning and reduced descriptor sets.

Authors:  Ibrahim Abdelbaky; Hilal Tayara; Kil To Chong
Journal:  Sci Rep       Date:  2021-01-12       Impact factor: 4.379

Review 8.  Trends in kinase drug discovery: targets, indications and inhibitor design.

Authors:  Misty M Attwood; Doriano Fabbro; Aleksandr V Sokolov; Stefan Knapp; Helgi B Schiöth
Journal:  Nat Rev Drug Discov       Date:  2021-08-05       Impact factor: 84.694

Review 9.  Protein Kinases: Potential Drug Targets Against Schistosoma japonicum.

Authors:  Kaijuan Wu; Xingyu Zhai; Shuaiqin Huang; Liping Jiang; Zheng Yu; Jing Huang
Journal:  Front Cell Infect Microbiol       Date:  2021-07-01       Impact factor: 5.293

Review 10.  Compounds from Natural Sources as Protein Kinase Inhibitors.

Authors:  Andrea Baier; Ryszard Szyszka
Journal:  Biomolecules       Date:  2020-11-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.